Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 4/20 | 0.49 |
| ▸ | PRKCA | P17252 | 5/20 | 0.48 |
| ▸ | PRKCE | Q02156 | 2/20 | 0.48 |
| ▸ | PRKCQ | Q04759 | 2/20 | 0.48 |
| ▸ | PRKCD | Q05655 | 2/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | DGKA | P23743 | 1/20 | 0.44 |
| ▸ | FAAH | O00519 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | CNR1 | P21554 | 1/20 | 0.42 |
| ▸ | CNR2 | P34972 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8502959 | 1.00 | MAPT (0.54) | MAPTMAPK1LMNAPRKCAPRKCE | |
| SCHEMBL769533 | 1.00 | MAPT (0.54) | MAPTMAPK1LMNAPRKCAPRKCE | |
| SCHEMBL2800456 | 1.00 | MAPT (0.54) | MAPTMAPK1LMNAPRKCAPRKCE | |
| SCHEMBL8190440 | 1.00 | MAPT (0.54) | MAPTMAPK1LMNAPRKCAPRKCE | |
| SCHEMBL15262436 | 1.00 | MAPT (0.54) | MAPTMAPK1LMNAPRKCAPRKCE | |
| SCHEMBL19458643 | 1.00 | MAPT (0.54) | MAPTMAPK1LMNAPRKCAPRKCE | |
| SCHEMBL15463455 | 1.00 | MAPT (0.54) | MAPTMAPK1LMNAPRKCAPRKCE | |
| SCHEMBL11801281 | 1.00 | MAPT (0.54) | MAPTMAPK1LMNAPRKCAPRKCE | |
| SCHEMBL6357113 | 1.00 | MAPT (0.54) | MAPTMAPK1LMNAPRKCAPRKCE | |
| SCHEMBL10763839 | 1.00 | MAPT (0.54) | MAPTMAPK1LMNAPRKCAPRKCE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 144 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113181073-B | Composite vitamin emulsion, wrinkle-removing essence cream and preparation method thereof | 广州市科能化妆品科研有限公司 | 2022-12-23 | — | — | CN | claimed |
| CN-111437214-B | Retinol inclusion, anti-aging and wrinkle-removing essence and preparation method thereof | 广州市科能化妆品科研有限公司 | 2022-05-13 | — | — | CN | claimed |
| CN-113181073-A | Composite vitamin emulsion, wrinkle-removing essence cream and preparation method thereof | 广州市科能化妆品科研有限公司 | 2021-07-30 | — | — | CN | claimed |
| US-20200236933-A1 | USE OF A NON-IONIC SURFACTANT WHICH IS A POLYOL DERIVATIVE AS A PLANT GROWTH STIMULATING AGENT OR AS AN ADJUVANT | INNOVI (FR) | 2020-07-30 | — | — | US | claimed |
| CN-111437214-A | Retinol inclusion, anti-aging and wrinkle-removing essence and preparation method thereof | 广州市科能化妆品科研有限公司 | 2020-07-24 | — | — | CN | claimed |
| CN-111432640-A | Use of nonionic surfactants of polyol derivatives as plant growth stimulators or as adjuvants | 宜诺维 | 2020-07-17 | — | — | CN | claimed |
| EP-3664610-A2 | USE OF A NON-IONIC SURFACTANT WHICH IS A POLYOL DERIVATIVE AS A PLANT GROWTH STIMULATING AGENT OR AS AN ADJUVANT | INNOVI (FR) | 2020-06-17 | — | — | EP | claimed |
| US-20180200180-A1 | MAGNOLIA BARK EXTRACT AS A HYDROPHOBIC LIGAND FOR PREFERENTIAL REMOVAL OF GRAM NEGATIVE BACTERIA FROM THE ORAL CAVITY | WM. WRIGLEY JR. COMPANY | 2018-07-19 | — | — | US | claimed |
| EP-3322487-A1 | MAGNOLIA BARK EXTRACT AS A HYDROPHOBIC LIGAND FOR PREFERENTIAL REMOVAL OF GRAM NEGATIVE BACTERIA FROM THE ORAL CAVITY | WM. Wrigley Jr. Company (US) | 2018-05-23 | — | — | EP | claimed |
| WO-2017011665-A1 | MAGNOLIA BARK EXTRACT AS A HYDROPHOBIC LIGAND FOR PREFERENTIAL REMOVAL OF GRAM NEGATIVE BACTERIA FROM THE ORAL CAVITY | WM. WRIGLEY JR. COMPANY (US) | 2017-01-19 | — | — | WO | claimed |
| US-12521342-B2 | Fast disintegrating tablet | CUBOPHARM PTY LTD (AU) | 2026-01-13 | — | — | US | disclosed |
| US-12521350-B2 | Liquid crystalline dosage form for administering a statin | CUBOPHARM PTY LTD (AU) | 2026-01-13 | — | — | US | disclosed |
| US-12441934-B2 | Viscosifying friction reducers | Energy Solutions (US) LLC (US) | 2025-10-14 | — | — | US | disclosed |
| US-12428593-B2 | Hydraulic fracturing fluids and methods of use with friction reducer slurry formulation | INDEPENDENCE OILFIELD CHEMICALS LLC (US) | 2025-09-30 | — | — | US | disclosed |
| WO-2025102064-A1 | FRICTION REDUCER POLYMERS FOR OILFIELD APPLICATIONS | Energy Solutions (US) LLC (US) | 2025-05-15 | — | — | WO | disclosed |
| US-5739190-A | Process for the preparation of stable water-in-oil emulsions of hydrolyzed polymers of N-vinyl amides and the use thereof | BASF AKTIENGESELLSCHAFT (DE) | 1998-04-14 | — | — | US | disclosed |
| WO-1994012651-A1 | ENZYMATIC SYNTHESIS OF SUGAR ALCOHOL ESTERS | NOVO NORDISK A/S (DK) | 1994-06-09 | — | — | WO | disclosed |
| US-5292800-A | Epichlorohydrin, alcohol, polyol, alkoxylation | BASF AKTIENGESELLSCHAFT (DE) | 1994-03-08 | — | — | US | disclosed |
| US-5162116-A | Intra-ruminal device for delivering drugs | COOPERS ANIMAL HEALTH LIMITED (GB) | 1992-11-10 | — | — | US | disclosed |
| EP-0373890-A1 | Intra-ruminal device | COOPERS ANIMAL HEALTH LIMITED (GB) | 1990-06-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180200180-A1 | MAGNOLIA BARK EXTRACT AS A HYDROPHOBIC LIGAND FOR PREFERENTIAL REMOVAL OF GRAM NEGATIVE BACTERIA FROM THE ORAL CAVITY | MLEC, CD14, HIRA | MAPT 3493/4885MAPK1 3997/4885LMNA 2010/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.